查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1973784

鍺-68/鎵-68發生器市場：按技術、發生器容量、應用和最終用戶分類－2026年至2032年全球預測

Germanium-68 Gallium-68 Generators Market by Technology, Generator Capacity, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，鍺-68/鎵-68 發生器市場價值將達到 445 億美元，到 2026 年將成長至 510.6 億美元，到 2032 年將達到 1,200.9 億美元，複合年成長率為 15.23%。

主要市場統計數據
基準年 2025 445億美元
預計年份：2026年 510.6億美元
預測年份 2032 1200.9億美元
複合年成長率 (%) 15.23%

簡單介紹鍺-68/鎵-68發生器技術如何改變醫療保健環境中的分散式PET示蹤劑供應和放射性藥物工作流程。

由發生器產生的正電子發射同位素領域仍然是分子成像和放射性藥物生產流程的核心。鍺-68/鎵-68發生器技術支援短壽命鎵-68的去中心化供應鏈，使醫院、診斷中心、研究機構和製藥公司無需即時使用迴旋加速器即可利用PET示蹤劑。隨著心臟病學、神經病學和腫瘤學領域對標靶PET診斷的臨床需求不斷成長，發生器系統也不斷改進以滿足不同的使用者需求，法規結構也不斷發展以保障病患安全和產品品質。

技術創新、將臨床應用擴展到腫瘤學以外的領域以及供應鏈的韌性正在推動基於發生器的 PET 同位素生態系統發生重大結構性變化。

技術創新、監管成熟和臨床模式的演變正在改變PET同位素發生器市場。自動化和整合系統結構降低了操作人員的差異性，並實現了多通道處理，從而滿足了商業生產和醫院放射性藥物部門日益成長的需求。這些技術進步輔以更完善的品管和數位化可追溯性，提高了對區域和國際監管要求的合規性。

對 2025 年美國關稅措施對整個發電機供應鏈的供應商重組、成本管理策略和採購趨勢的影響進行分析研究。

2025年美國的關稅環境為發電機系統及相關耗材的供應商和終端用戶帶來了新的營運和策略壓力。對進口零件和成品發電機徵收的關稅措施改變了依賴全球化生產鏈的製造商的成本結構，促使他們重新評估籌資策略，並促使一些供應商考慮將生產外包或在美國國內組裝，以減輕額外的進口關稅影響。這些商業性因應措施對醫院、診斷中心和商業放射性藥物藥局的採購計畫、庫存政策和資本投資決策產生了顯著的連鎖反應。

詳細的細分分析揭示了應用、最終用戶、技術類型和發電機容量如何相互作用，從而確定採購優先順序和營運設計選擇。

要了解市場，需要對多個細分維度進行細緻分析，這些維度決定了技術選擇、營運規模和最終用戶價值。依應用領域分類，市場可分為PET成像和放射性藥物生產。 PET影像本身涵蓋心臟病學、神經病學和腫瘤學等領域的應用，其中示蹤劑特異性和成像頻率會影響發生器的利用率。另一方面，放射性藥物生產又分為商業生產和科學研究生產環境，兩者各自有獨特的產能和監管要求。

從區域來看，美洲、歐洲、中東和非洲以及亞太地區在實施模式、法規環境和採購行為方面存在明顯差異。

區域趨勢對整個發生器生態系統的技術採用模式、監管要求和投資重點都有顯著影響。在美洲，成熟的臨床PET部署和廣泛的醫院網路正在推動對自動化柱狀系統和整合多通道配置的需求。同時，分銷物流和區域製造能力影響集中式生產和分散式生產之間的選擇。向數位化品質體系的轉變以及對門診影像中心日益成長的興趣也在影響著採購決策和服務模式。

領先的發電機供應商如何透過結合自動化、服務生態系統、監管準備和供應鏈多元化來實現差異化並穩定收入來源？

發生器領域的競爭者正在探索創新、服務差異化和供應鏈最佳化之間的複雜互動，以期與臨床和工業客戶建立長期合作關係。主要參與者正在加速投資自動化、數位化品管和多通路架構，以滿足多樣化的需求，同時建立包括耗材供應、預防性保養和培訓計畫在內的服務生態系統，旨在減少停機時間並確保合規性。與放射性藥物藥房和契約製造建立策略合作夥伴關係正變得越來越普遍，這使得技術提供者能夠參與到更廣泛的價值鏈中，其範圍不僅限於硬體，還包括長期試劑供應和商業規模生產。

供應商和機構買家應採取切實可行的策略重點，以加快採用速度、增強韌性，並使商業模式與臨床需求保持一致。

產業領導者應推動一系列合作舉措，以鞏固市場地位、提升韌性並加速採用發生器型PET示蹤劑。首先，應優先開發和實施自動化整合系統，以減少對操作人員的依賴並確保可重複的品質。將硬體與數位品管和遠距離診斷功能整合，將提高運轉率並支援可擴展的生產模式。其次，應採用靈活的商業性安排，例如租賃、計量收費和捆綁式服務契約，以降低醫院系統和診斷中心的准入門檻，同時確保收入和維護流程的可預測性。

我們嚴謹的混合研究途徑，結合相關人員訪談、監管審查、技術文件分析和跨細分市場整合，揭示了可操作的行業洞察。

本分析的調查方法結合了定性和定量技術，旨在了解整個發生器生態系統中的技術趨勢、相關人員的優先事項和營運考慮。主要工作包括與各類相關人員進行結構化訪談，這些利益相關者包括放射性藥物管理人員、醫院採購負責人、診斷中心運營人員、研究實驗室管理人員、技術供應商和監管專家，以深入了解推動技術應用、維護實踐和檢驗要求等方面的實用見解。此外，還進行了二次研究，查閱了監管指南、技術白皮書、關於PET在心臟病學、神經病學和腫瘤學領域應用的臨床文獻以及供應商技術文檔，以檢驗產品功能和市場定位。

觀點是，技術進步、監管協調和供應鏈策略將是全面決定發生器輔助 PET 同位素獲取未來的關鍵因素。

總之，鎵-68發生器的供應處於臨床應用機會與營運複雜性的交會點。技術創新，特別是自動化和整合系統設計的進步，顯著提高了院內示踪劑生產的可靠性和擴充性，使其在心臟病學、神經病學和腫瘤學等領域得到廣泛應用，同時也為研發和商業規模的放射性藥物生產提供了支持。同時，供應鏈和政策的發展，包括關稅趨勢，正促使製造商和終端用戶在採購、服務模式和資本規劃方面進行策略調整。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：鍺-68/鎵-68發生器市場：依技術分類

  • 基於列
    • 自動化
    • 手動的
  • 整合系統
    • 多通道
    • 單通道

第9章：鍺-68/鎵-68發電機市場（依發電機容量分類）

  • 高容量
  • 小容量
  • 中等容量

第10章：鍺-68/鎵-68發生器市場：依應用領域分類

  • PET影像
    • 心臟病學
    • 神經病學
    • 腫瘤學
  • 放射性藥物生產
    • 商業生產
    • 調查生產

第11章：鍺-68/鎵-68發生器市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 製藥公司
  • 研究機構

第12章：鍺-68/鎵-68發生器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：鍺-68/鎵-68發生器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：鍺-68/鎵-68發生器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國鍺-68/鎵-68發生器市場

第16章：中國鍺-68/鎵-68發生器市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Accelerator Applications
  • Anderson Publishing, Ltd.
  • BJ Madan & Co
  • BWX Technologies. Inc.
  • Cardinal Health.
  • Curium Pharma
  • Cyclotron Co. Ltd.
  • Eckert & Ziegler Radiopharma GmbH
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • EDH Nuclear Medicine & Healtcare Services Ltd.
  • IBA Worldwide
  • Isotope JSC
  • Isotopia Molecular Imaging Ltd.
  • Kompass International SA
  • Lemer Pax
  • RadioMedix Inc.
  • Telix Pharmaceuticals Limited.
  • TEMA Sinergie
Product Code: MRR-546E6FBB361C

The Germanium-68 Gallium-68 Generators Market was valued at USD 44.50 billion in 2025 and is projected to grow to USD 51.06 billion in 2026, with a CAGR of 15.23%, reaching USD 120.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.50 billion
Estimated Year [2026] USD 51.06 billion
Forecast Year [2032] USD 120.09 billion
CAGR (%) 15.23%

A concise introduction to how Germanium-68/Gallium-68 generator technology is reshaping decentralized PET tracer supply and radiopharmaceutical workflows across care settings

The field of generator-produced positron-emitting isotopes remains central to molecular imaging and radiopharmaceutical production workflows. Germanium-68/Gallium-68 generator technology underpins decentralized supply chains for short-lived gallium-68, enabling hospitals, diagnostic centers, research institutes, and pharmaceutical companies to access PET tracers without reliance on immediate cyclotron access. As clinical demand for targeted PET diagnostics spreads across cardiology, neurology, and oncology, generator systems are adapting to meet heterogeneous user requirements while regulatory frameworks evolve to maintain patient safety and product quality.

Transitioning from historical, predominantly manual generator models, the industry now shows pronounced movement toward automated and integrated solutions that increase throughput, reproducibility, and compliance with current good manufacturing practices. This shift is occurring alongside intensified focus on supply chain resilience, where generator capacity segmentation from low to high capacity influences procurement strategies for commercial production versus research applications. Collectively, these dynamics are reshaping how end users evaluate technology choices, partner with suppliers, and structure their internal radiopharmacy operations to deliver consistent, high-quality PET imaging agents.

How technological innovation, clinical expansion beyond oncology, and supply chain resilience are driving major structural change in generator-based PET isotope ecosystems

The landscape for generator-sourced PET isotopes is undergoing transformative shifts driven by technological innovation, regulatory maturation, and evolving clinical paradigms. Automation and integrated system architectures are reducing operator variability and enabling multi-channel throughput, which in turn supports growing demand from both commercial production and high-volume hospital radiopharmacies. These technology advances are complemented by enhanced quality controls and digitally enabled traceability, which strengthen compliance with regional and international regulatory expectations.

Concurrently, clinical adoption of PET tracers beyond oncology-most notably in neurology and cardiology-has broadened the end-user base, prompting diagnostic centers and research institutes to reconsider on-site production capabilities. Supply chain strategies are also transforming: organizations are balancing the flexibility of local generator use against centralized manufacturing models, and many are investing in medium- to high-capacity generators that can serve multi-site networks. As these shifts unfold, strategic partnerships between technology providers, radiopharmacies, and clinical networks are emerging as a dominant theme, enabling faster translation of novel tracers into routine clinical pathways and more resilient access to isotopes for patient care.

An analytical review of how 2025 US tariff measures catalyzed sourcing realignment, cost management strategies, and procurement shifts across the generator supply chain

The tariff environment in the United States in 2025 introduced a new vector of operational and strategic pressure for suppliers and end users of generator systems and related consumables. Tariff measures applied to imported components and finished generator units altered cost structures for manufacturers that rely on globalized production chains, prompting reassessment of sourcing strategies and prompting some suppliers to explore nearshoring or domestic assembly to mitigate added import duties. These commercial reactions have important knock-on effects for procurement timelines, inventory policies, and capital expenditure decisions among hospitals, diagnostic centers, and commercial radiopharmacies.

As organizations adjusted to higher landed costs, purchasing behavior shifted toward longer-term service contracts, extended maintenance agreements, and a preference for integrated systems that could maximize uptime and throughput. Research institutes and smaller diagnostic centers faced particular strain when tariffs increased the price of replacement columns, shielding, and ancillary components, which accelerated consolidation of maintenance services and incentivized multi-year supply agreements. In response, some manufacturers restructured product portfolios to favor modular solutions that reduce customs exposure, while others intensified collaboration with regional distributors to smooth supply and offset tariff impacts through bundled service offerings. Overall, the tariff landscape of 2025 catalyzed a strategic reorientation across the value chain from sourcing to after-sales support, with resilience and total cost of ownership becoming decisive procurement criteria.

In-depth segmentation analysis revealing how applications, end users, technology types, and generator capacity jointly determine procurement priorities and operational design choices

Understanding the market requires a nuanced view across multiple segmentation axes that determine technology selection, operational scale, and end-user value. Based on application, the market divides between PET imaging and radiopharmaceutical production; PET imaging itself spans cardiology, neurology, and oncology use cases where tracer specificity and imaging cadence drive generator utilization, while radiopharmaceutical production separates into commercial production and research production environments, each with distinct throughput and regulatory demands.

From an end-user perspective, diagnostic centers, hospitals, pharmaceutical companies, and research institutes present diverse adoption drivers and constraints: diagnostic centers prioritize ease of use and routine tracer availability; hospitals emphasize integration with clinical workflows and compliance; pharmaceutical companies focus on scalable production and GMP alignment; research institutes value flexibility and experimental throughput. Technology segmentation distinguishes column-based and integrated systems; column-based options further differentiate between automated and manual approaches, influencing operator skill requirements and process consistency, while integrated systems are available as multi-channel or single-channel configurations to match throughput needs. Finally, generator capacity segmentation into high capacity, medium capacity, and low capacity defines which applications are feasible on-site and how sites balance capital expenditure against anticipated tracer demand. Together, these segmentation lenses illuminate paths for technology deployment, service models, and strategic partnerships across different organizational types and operational scales.

Regional examination of how the Americas, Europe Middle East & Africa, and Asia-Pacific exhibit distinct adoption patterns, regulatory contexts, and procurement behaviors

Regional dynamics exert a pronounced influence on technology adoption patterns, regulatory expectations, and investment priorities across the generator ecosystem. In the Americas, mature clinical PET adoption combined with extensive hospital networks has cultivated demand for both automated column-based systems and integrated multi-channel configurations, while distribution logistics and regional manufacturing capacity shape choices about centralized versus decentralized production. Transitioning to digital quality systems and increased interest in outpatient imaging centers also informs procurement decisions and service models.

The Europe, Middle East & Africa region presents a mosaic of regulatory regimes and infrastructure maturity, with pockets of highly advanced radiopharmacy capacity in Western Europe alongside emerging adoption in select Middle Eastern markets and evolving capabilities in parts of Africa. This diversity drives demand for scalable generator capacities and versatile technologies that can function reliably across disparate environments. In the Asia-Pacific region, rapid expansion of diagnostic services and growing investment in precision medicine are accelerating uptake of higher-capacity generators and integrated automated workflows, while regional manufacturing ecosystems and government-led healthcare initiatives influence localization strategies and partnership models. These regional differences underscore the importance of tailored commercial approaches, local regulatory navigation, and flexible service propositions for suppliers and institutional buyers alike.

How leading generator suppliers are combining automation, service ecosystems, regulatory readiness, and supply chain diversification to differentiate and stabilize revenue streams

Competitors in the generator space are navigating a complex interplay of innovation, service differentiation, and supply chain optimization to secure durable relationships with clinical and industrial customers. Leading players are accelerating investment in automation, digital quality management, and multi-channel architectures to address demand heterogeneity, while simultaneously developing service ecosystems that include consumable supply, preventive maintenance, and training programs to reduce downtime and ensure compliance. Strategic partnerships with radiopharmacies and contract manufacturers are increasingly common, enabling technology providers to participate in broader ecosystem value chains that extend beyond hardware into long-term reagent supply and commercial-scale production.

At the same time, companies are prioritizing regulatory readiness by investing in validation protocols, documentation frameworks, and traceability solutions that facilitate market entry across multiple jurisdictions. Competitive differentiation also arises from modular product offerings that allow customers to scale capacity as clinical or commercial needs evolve, and from financing or leasing models that lower upfront capital barriers for hospitals and diagnostic centers. In response to tariff pressures and supply chain volatility, manufacturers are diversifying sourcing, exploring regional assembly options, and enhancing distributor relationships to protect lead times. Collectively, these strategic moves reflect an industry balancing technological leadership with pragmatic commercial models that prioritize uptime, compliance, and predictable lifetime costs for end users.

Actionable strategic priorities for suppliers and institutional purchasers to accelerate adoption, strengthen resilience, and align commercial models with clinical demand

Industry leaders should pursue a coordinated set of actions to strengthen market position, enhance resilience, and accelerate adoption of generator-enabled PET tracers. First, prioritize development and deployment of automated and integrated systems that reduce operator dependency and ensure reproducible quality; coupling hardware with digital quality management and remote diagnostic capabilities will improve uptime and support scalable production models. Next, adopt flexible commercial arrangements, including leasing, pay-per-use, and bundled service contracts, to lower barriers for hospital systems and diagnostic centers while creating predictability in revenue and maintenance flows.

Additionally, invest in regional supply chain strategies that combine local assembly or final-stage manufacturing with robust distributor partnerships to mitigate tariff and logistics risks. Build regulatory readiness into product roadmaps by standardizing validation packages and harmonizing documentation to ease cross-border market entry. Strengthen collaborations with pharmaceutical companies and contract development and manufacturing organizations to support tracer commercialization pathways, and offer tailored solutions for research institutes that emphasize modularity and experimental flexibility. Finally, expand training and workforce development initiatives to ensure end users can safely and efficiently operate evolving technologies, thereby accelerating clinical adoption and fostering long-term customer loyalty.

A rigorous mixed-methods research approach combining stakeholder interviews, regulatory review, technical documentation analysis, and cross-segmentation synthesis to surface practical industry insights

The research methodology underpinning this analysis combined qualitative and quantitative techniques to capture technological trends, stakeholder priorities, and operational considerations across the generator ecosystem. Primary engagement included structured interviews with a range of stakeholders such as radiopharmacy managers, hospital procurement officers, diagnostic center operators, research laboratory leads, technology suppliers, and regulatory specialists to surface practical insights about adoption drivers, maintenance practices, and validation expectations. These conversations were complemented by secondary research that reviewed regulatory guidance, technology white papers, clinical literature on PET applications across cardiology, neurology, and oncology, and supplier technical documentation to verify product capabilities and positioning.

Analytical methods incorporated cross-segmentation synthesis, wherein application, end-user, technology, and capacity lenses were overlaid to identify consistent patterns and divergences in requirements. Scenario analysis explored the effects of supply chain disruptions and cost pressures-such as tariff changes-on procurement decisions and lifecycle costs, while vendor benchmarking assessed strategic approaches to automation, service delivery, and regulatory compliance. Where appropriate, findings were triangulated across sources to increase confidence in observed trends and to distinguish durable structural changes from transient market responses, ensuring the conclusions reflect current industry realities and practical implications for decision-makers.

Concluding perspective on how technological advances, regulatory alignment, and supply chain strategy collectively determine the future trajectory of generator-enabled PET isotope access

In sum, generator-based access to gallium-68 sits at the intersection of clinical opportunity and operational complexity. Technological innovation-particularly in automation and integrated system design-has materially improved the reliability and scalability of on-site tracer production, enabling broader clinical application across cardiology, neurology, and oncology as well as supporting both research and commercial-scale radiopharmaceutical production. Concurrently, supply chain and policy developments, including tariff dynamics, have prompted strategic realignment in sourcing, service models, and capital planning across manufacturers and end users.

Looking forward, suppliers that combine robust service ecosystems, modular product architectures, and regulatory-ready validation packages will be best positioned to capture durable customer relationships. End users that balance capacity planning with flexible procurement arrangements and invest in staff training will realize the greatest operational resilience and clinical throughput. Together, these factors indicate a market environment where technological capability, regulatory compliance, and pragmatic commercial design determine how effectively stakeholders convert generator access into reliable PET imaging and radiopharmaceutical outputs for patient care and research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Germanium-68 Gallium-68 Generators Market, by Technology

  • 8.1. Column Based
    • 8.1.1. Automated
    • 8.1.2. Manual
  • 8.2. Integrated Systems
    • 8.2.1. Multi Channel
    • 8.2.2. Single Channel

9. Germanium-68 Gallium-68 Generators Market, by Generator Capacity

  • 9.1. High Capacity
  • 9.2. Low Capacity
  • 9.3. Medium Capacity

10. Germanium-68 Gallium-68 Generators Market, by Application

  • 10.1. Pet Imaging
    • 10.1.1. Cardiology
    • 10.1.2. Neurology
    • 10.1.3. Oncology
  • 10.2. Radiopharmaceutical Production
    • 10.2.1. Commercial Production
    • 10.2.2. Research Production

11. Germanium-68 Gallium-68 Generators Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Germanium-68 Gallium-68 Generators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Germanium-68 Gallium-68 Generators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Germanium-68 Gallium-68 Generators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Germanium-68 Gallium-68 Generators Market

16. China Germanium-68 Gallium-68 Generators Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Accelerator Applications
  • 17.6. Anderson Publishing, Ltd.
  • 17.7. B. J. Madan & Co
  • 17.8. BWX Technologies. Inc.
  • 17.9. Cardinal Health.
  • 17.10. Curium Pharma
  • 17.11. Cyclotron Co. Ltd.
  • 17.12. Eckert & Ziegler Radiopharma GmbH
  • 17.13. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 17.14. EDH Nuclear Medicine & Healtcare Services Ltd.
  • 17.15. IBA Worldwide
  • 17.16. Isotope JSC
  • 17.17. Isotopia Molecular Imaging Ltd.
  • 17.18. Kompass International SA
  • 17.19. Lemer Pax
  • 17.20. RadioMedix Inc.
  • 17.21. Telix Pharmaceuticals Limited.
  • 17.22. TEMA Sinergie

LIST OF FIGURES

  • FIGURE 1. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HIGH CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY LOW CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY MEDIUM CAPACITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COMMERCIAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 156. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 160. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 183. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 185. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 192. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 196. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY COLUMN BASED, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY GENERATOR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA GERMANIUM-68 GALLIUM-68 GENERATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)